LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.15 | 17.25 | 4640 | 5061 | 0.9168 | 0.9789 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.15 | 17.25 | 3374 | 5061 | 0.6667 | 0.9035 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.15 | 17.25 | 4982 | 5061 | 0.9844 | 0.9962 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.12 | 17.25 | 30 | 5095 | 0.0059 | 0.0697 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.12 | 17.25 | 4861 | 5095 | 0.9540 | 0.9886 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.12 | 17.25 | 2617 | 5095 | 0.5136 | 0.8440 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.12 | 17.25 | 5223 | 5095 | 1.0251 | 1.0060 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.09 | 17.25 | 34 | 5221 | 0.0065 | 0.0858 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.09 | 17.25 | 5051 | 5221 | 0.9674 | 0.9920 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.09 | 17.25 | 2372 | 5221 | 0.4543 | 0.8174 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.09 | 17.25 | 5420 | 5221 | 1.0381 | 1.0091 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.06 | 17.25 | 29 | 5242 | 0.0055 | 0.0650 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.06 | 17.25 | 5256 | 5242 | 1.0025 | 1.0006 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.06 | 17.25 | 2288 | 5242 | 0.4364 | 0.8087 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.06 | 17.25 | 5678 | 5242 | 1.0830 | 1.0194 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.03 | 17.25 | 8 | 5367 | 0.0015 | -0.0886 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.03 | 17.25 | 5414 | 5367 | 1.0087 | 1.0021 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.03 | 17.25 | 1639 | 5367 | 0.3054 | 0.7331 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.03 | 17.25 | 5815 | 5367 | 1.0835 | 1.0195 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.00 | 17.25 | 35 | 5546 | 0.0063 | 0.0887 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.00 | 17.25 | 5606 | 5546 | 1.0107 | 1.0025 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.00 | 17.25 | 1381 | 5546 | 0.2490 | 0.6925 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.00 | 17.25 | 5958 | 5546 | 1.0741 | 1.0172 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.97 | 17.25 | 28 | 5618 | 0.0050 | 0.0597 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.97 | 17.25 | 5822 | 5618 | 1.0362 | 1.0085 | MN20160310_N02 | K22 |